The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future.

Item

http://www.wikidata.org/entity/Q38817384

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The renin-angiotensin-aldoster ...... t, the present and the future.

@en

type

Item

label

The renin-angiotensin-aldoster ...... t, the present and the future.

@en

prefLabel

The renin-angiotensin-aldoster ...... t, the present and the future.

@en

P1476

The renin-angiotensin-aldoster ...... t, the present and the future.

@en

P2093

Parminder S Chaggar

http://www.w3.org/2001/XMLSchema#string

Simon G Williams

http://www.w3.org/2001/XMLSchema#string

Steven M Shaw

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin-neprilysin inhibition versus enalapril in heart failure

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Recent progress in angiotensin II type 2 receptor research in the cardiovascular system.

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

P304

29-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/POSTGRADMEDJ-2016-134045

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1095

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Christopher Orsborne

P577

2016-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27671772

http://www.w3.org/2001/XMLSchema#string